AstroNova Reports Fiscal 2025 Fourth-Quarter and Full-Year Financial Results; Advancing Restructuring, Operational Realignment and Product Simplification Plans to Drive Improved Earnings Power

April 15, 2025

 

The Condensed Consolidated Statements of Cash Flows and Reconciliation of GAAP to Non-GAAP Items for PI Segment tables of release dated April 14, 2025 have been updated.

The updated release reads:

ASTRONOVA REPORTS FISCAL 2025 FOURTH-QUARTER AND FULL-YEAR FINANCIAL RESULTS; ADVANCING RESTRUCTURING, OPERATIONAL REALIGNMENT AND PRODUCT SIMPLIFICATION PLANS TO DRIVE IMPROVED EARNINGS POWER

  • Fourth quarter revenue of $37.4 million in line with preliminary expectations; fiscal 2025 revenue of $151.3 million comprised of 71% recurring revenue
  • Restructuring plan expected to deliver $3 million in annualized savings with 40% to be realized in fiscal 2026
  • Simplifying product portfolio; focused on higher growth higher margin products
  • Aerospace Test & Measurement segment ToughWriter printer transition 40% complete; drives operational efficiency and reduced working capital requirements while eliminating legacy royalties

AstroNova, Inc. (Nasdaq: ALOT), a global leader in data visualization technologies, today announced financial results for its fiscal 2025 fourth quarter and full-year ended January 31, 2025. Results include the May 6, 2024 acquisition of MTEX NS.

Greg Woods, President and Chief Executive Officer of AstroNova, stated, “Fiscal 2025 was a challenging year as we addressed the difficult integration of MTEX, absorbed the impact of the Boeing strike and addressed the timing associated with large defense industry orders. Nonetheless, we aggressively implemented the AstroNova Operating System at MTEX, improved the leadership team, upgraded talent within the organization, and significantly improved the accounting and finance system and human resources processes. We are instilling accountability and discipline into the organization, streamlining the structure and eliminating waste. We have also identified how to best leverage MTEX’s operations in Portugal to create an AstroNova Center of Manufacturing Excellence in Europe. In fact, we are taking action throughout AstroNova to create a business that can deliver stronger earnings power.”

“Importantly, we are leveraging the innovative foundation of MTEX technologies to create more competitive solutions that address an expanded range of applications and provide our customers with higher quality and reliability. This will also enable us to gain greater control over our supply chain in order to reduce costs and expand margins. We plan to launch new products incorporating our next-generation technology in the first quarter of fiscal 2026 and will be rolling out more products throughout the year.”

Fiscal 2026 Outlook Reaffirmed

For fiscal 2026, AstroNova continues to expect net revenue in the range of $160 million to $165 million which is a 7% increase over fiscal 2025 at the mid-point of the range. Adjusted EBITDA margin is expected to be in the range of 8.5% to 9.5%, a 60-basis point expansion over the prior year at the mid-point.

Mr. Woods added, “We are focused on innovative solutions to gain market share and expand our market reach. Our strategic priorities in fiscal 2026 are to drive our print engine technology initiatives, capture greater ownership of the supply chain for our consumables, and drive the conversion to our ToughWriter family of printers with our Aerospace customers. In addition to offering a better solution for our customers, this conversion and other product simplification initiatives will reduce inventory, improve working capital and drive profitability.”

Fourth Quarter Fiscal 2025 Overview

Net revenue for the fourth quarter of fiscal 2025 was $37.4 million compared with net revenue of $39.6 million for the fourth quarter of fiscal 2024, a decrease of 5.6% or $2.2 million, reflecting lower sales in both Product Identification (PI) and Test & Measurement (T&M) segments.

PI revenue was $25.7 million for the fourth quarter of fiscal 2025 compared with $26.6 million for the fourth quarter of fiscal 2024, a decrease of 3.6% or $0.9 million. The decrease was primarily attributable to less favorable product mix in the 2025 period, partially offset by the addition of MTEX, which the Company acquired in May 2024.

On a GAAP (Generally Accepted Accounting Principles) basis, PI segment operating loss was $11.2 million for the fourth quarter of fiscal 2025, which includes the previously announced non-cash goodwill impairment of $13.4 million largely associated with the Company’s MTEX business and $0.1 million in inventory step-up expenses. This compares with PI segment GAAP operating profit of $3.2 million, or 12.2% of segment revenue, for the fourth quarter of fiscal 2024, which includes $0.3 million in product retrofit costs and restructuring charges. On a non-GAAP basis, excluding the discrete expenses in both periods, PI segment operating profit was $2.3 million, or 8.9% of segment revenue in the fourth quarter of fiscal 2025, compared with segment operating profit of $3.0 million, or 11.1% of segment revenue, for the fourth quarter of fiscal 2024.

T&M segment revenue was $11.7 million for the fourth quarter of fiscal 2025 compared with $13.0 million for the fourth quarter of fiscal 2024, a decrease of 9.9% or $1.3 million. The decrease was due primarily to a delayed defense order and, to a lesser extent, deferred deliveries associated with the Boeing strike.

T&M segment operating profit was $2.3 million, or 20.0% of segment revenue, for the fourth quarter of fiscal 2025 compared with segment operating profit of $3.7 million, or 28.2% of segment revenue, for the fourth quarter of fiscal 2024.

GAAP gross profit was $12.7 million for the fourth quarter of fiscal 2025, resulting in a gross margin of 34.1%, compared with gross profit of $14.7 million and a gross profit of 37.2% for the same period in fiscal 2024, primarily reflecting lower revenue and less favorable product mix in the 2025 period.

GAAP operating loss for the fourth quarter of fiscal 2025 was $12.3 million, compared with GAAP operating income of $3.9 million for the fourth quarter of fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported operating income of $1.4 million, compared with $3.6 million in the fourth quarter of fiscal 2024.

Net loss on a GAAP basis was $15.6 million, or $2.07 per share, for the fourth quarter of fiscal 2025 compared with net income of $2.7 million, or $0.36 per diluted share, for the fourth quarter of fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported net income of $0.4 million, or $0.06 per diluted share, for the fourth quarter of fiscal 2025 compared with net income of $2.5 million, or $0.33 per diluted share, in the fourth quarter of fiscal 2024.

Adjusted EBITDA was $2.8 million for the fourth quarter of fiscal 2025 compared with Adjusted EBITDA $5.2 million for the fourth quarter of fiscal 2024.

The Company’s order backlog was $28.3 million as of January 31, 2025 compared with $31.4 million at the end of fiscal 2024.

Full-Year Fiscal 2025 Overview

Net revenue for fiscal 2025 was $151.3 million compared with net revenue of $148.1 million for fiscal 2024, an increase of 2.2% or $3.2 million, reflecting higher sales in the T&M segment, partially offset by lower sales in the PI segment.

PI revenue was $102.3 million for fiscal 2025 compared with $104.0 million for fiscal 2024, a decrease of 1.6% or $1.7 million. The decrease was primarily attributable to less favorable product mix in the 2025 period, partially offset by the addition of MTEX, which the Company acquired in May 2024.

On a GAAP (Generally Accepted Accounting Principles) basis, PI segment operating loss was $4.0 million for fiscal 2025, which includes the previously announced non-cash goodwill impairment of $13.4 million largely associated with the Company’s MTEX business and $0.2 million in inventory step-up expenses. This compares with PI segment GAAP operating profit of $10.1 million, or 9.7% of segment revenue, for fiscal 2024, which includes $3.2 million in product retrofit costs and restructuring charges. On a non-GAAP basis, excluding the discrete expenses in both periods, PI segment operating profit was $9.7 million, or 9.4% of segment revenue, for fiscal 2025, compared with segment operating profit of $13.2 million, or 12.7% of segment revenue, for fiscal 2024.

T&M segment revenue was $48.9 million for fiscal 2025 compared with $44.0 million fiscal 2024, an increase of 11.1% or $4.9 million. The increase primarily reflected higher revenue from supplies and service/other in the 2025 period, partly offset by lower hardware sales.

T&M segment operating profit was $11.1 million, or 22.8% of segment revenue, fiscal 2025 compared with segment operating profit of $10.2 million, or 23.2% of segment revenue, for fiscal 2024.

GAAP gross profit was $52.7 million for fiscal 2025, resulting in a gross margin of 34.9%, compared with gross profit of $51.6 million and a gross profit of 34.9% for fiscal 2024.

GAAP operating loss for fiscal 2025 was $8.6 million, compared with GAAP operating income of $8.8 million for fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported operating income of $6.6 million for fiscal 2025, compared with $12.0 million for fiscal 2024, primarily related to higher operating expenses in the 2025 period.

Net loss on a GAAP basis was $14.5 million, or $1.93 per share, for fiscal 2025 compared with net income of $4.7 million, or $0.63 per diluted share, for fiscal 2024. On a non-GAAP basis, excluding discrete items in both periods, the Company reported net income of $2.7 million, or $0.33 per diluted share, in fiscal 2025 compared with net income of $7.2 million, or $0.97 per diluted share, in fiscal 2024.

Adjusted EBITDA was $12.3 million for fiscal 2025 compared with Adjusted EBITDA $17.6 million for fiscal 2024.

Amendment and Waiver of Credit Agreement

As previously disclosed, AstroNova obtained an amendment and waiver with regard to its credit agreement with Bank of America. Among other changes to the credit agreement, the amendment waives certain covered covenants as of the end of its fiscal quarter ended January 31, 2025, provides for relaxed financial covenant ratios during fiscal 2026, and provides for reduced payments of one of its term loans during fiscal 2026 as the Company implements its restructuring efforts, after which the payments of such term loan increase. The amended credit agreement provides for up to $2 million in add-backs to the Company’s Consolidated EBITDA (as defined in the credit agreement) for Company cash restructuring charges in fiscal 2026.

Earnings Conference Call Information

AstroNova will discuss its fiscal fourth-quarter and full-year fiscal 2025 financial results and business outlook in an investor conference call at 9:00 a.m. ET today. To access the conference call, please dial (833) 470-1428 (U.S. and Canada) or (404) 975-4839 (International) approximately 10 minutes prior to the start time and enter access code 957215.

A real-time and an archived audio webcast of the call will be available through the “Investors” section of the AstroNova website, https://investors.astronovainc.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the non-GAAP financial measures non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income, non-GAAP net income per diluted share, non-GAAP segment operating profit, and Adjusted EBITDA. AstroNova believes that the inclusion of these non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a non-GAAP basis. AstroNova’s management uses these non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the non-GAAP measures to the most directly comparable GAAP measures for the three and 12 months ended January 31, 2025 and 2024.

AstroNova has not reconciled the forward-looking Adjusted EBITDA growth percentage included in its fiscal 2026 financial targets and outlook to the most directly comparable forward-looking GAAP measure because this cannot be done without unreasonable effort due to the lack of predictability regarding cost of sales, operating expenses, depreciation and amortization, and stock-based compensation. The impact of any of these items, individually or in the aggregate, may be significant.

About AstroNova

AstroNova (Nasdaq: ALOT), a global leader in data visualization technologies since 1969, designs, manufactures, distributes and services a broad range of products that acquire, store, analyze, and present data in multiple formats.

The Product Identification segment provides a wide array of digital, end-to-end product marking and identification solutions, including hardware, software, and supplies for OEMs, commercial printers, and brand owners. The Test and Measurement segment provides products designed for airborne printing solutions, avionics, and data acquisition. Our aerospace products include flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. Our data acquisition systems are used in research and development, flight testing, missile and rocket telemetry production monitoring, power, and maintenance applications.

AstroNova is a member of the Russell Microcap® Index and the LD Micro Index (INDEXNYSEGIS: LDMICRO). Additional information is available by visiting https://astronovainc.com/.

Forward-Looking Statements

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that our organizational improvements at MTEX may not result in the benefits that we expect; (ii) the risk that our cost-reduction and product line rationalization initiative may not provide the expected benefits; (iii) the risk that our Aerospace customers may not convert to our ToughWriter line in the volumes or on the schedule that we expect; (iv) the risk that we may not realize the anticipated benefits of our next-generation print engine technology; and (v) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

   
ASTRONOVA, INC.  
Condensed Consolidated Statements of Income  
In Thousands Except for Per Share Data  
(Unaudited)  
           
    Three Months Ended  
    January 31,
2025
  January 31,
2024
 
Net Revenue  

$

37,361

 

 

$

39,594

 

 
Cost of Revenue  

 

24,624

 

 

 

24,848

 

 
Gross Profit  

 

12,737

 

 

 

14,746

 

 
Total Gross Profit Margin  

 

34.1

%

 

 

37.2

%

 
Operating Expenses:          
Selling & Marketing  

 

6,421

 

 

 

5,977

 

 
Research & Development  

 

1,751

 

 

 

1,878

 

 
General & Administrative  

 

3,473

 

 

 

2,976

 

 
Goodwill Impairment  

 

13,403

 

 

 

 

 
Total Operating Expenses  

 

25,048

 

 

 

10,831

 

 
Operating Income (Loss)  

 

(12,311

)

 

 

3,915

 

 
Total Operating Margin  

 

(33.0

)%

 

 

9.9

%

 
Interest Expense  

 

847

 

 

 

779

 

 
Other (Income)/Expense, net  

 

100

 

 

 

(216

)

 
Income (Loss) Before Taxes  

 

(13,258

)

 

 

3,352

 

 
Income Tax Provision  

 

2,342

 

 

 

641

 

 
Net Income (Loss)  

$

(15,600

)

 

$

2,711

 

 
Net Income (Loss) per Common Share - Basic  

$

(2.07

)

 

$

0.36

 

 
Net Income (Loss) per Common Share - Diluted  

$

(2.07

)

 

$

0.36

 

 
           
Weighted Average Number of Common Shares - Basic  

 

7,534

 

 

 

7,438

 

 
Weighted Average Number of Common Shares - Diluted  

 

7,534

 

 

 

7,550

 

 
           
           
    Twelve Months Ended  
    January 31,
2025
  January 31,
2024
 
Net Revenue  

$

151,283

 

 

$

148,086

 

 
Cost of Revenue  

 

98,534

 

 

 

96,465

 

 
Gross Profit  

 

52,749

 

 

 

51,621

 

 
Total Gross Profit Margin  

 

34.9

%

 

 

34.9

%

 
Operating Expenses:          
Selling & Marketing  

 

25,560

 

 

 

24,428

 

 
Research & Development  

 

6,610

 

 

 

6,906

 

 
General & Administrative  

 

15,816

 

 

 

11,491

 

 
Goodwill Impairment  

 

13,403

 

 

 

 

 
Total Operating Expenses  

 

61,389

 

 

 

42,825

 

 
Operating Income (Loss)  

 

(8,640

)

 

 

8,796

 

 
Total Operating Margin  

 

(5.7

)%

 

 

5.9

%

 
Interest Expense  

 

3,210

 

 

 

2,697

 

 
Other (Income)/Expense, net  

 

437

 

 

 

26

 

 
Income (Loss) Before Taxes  

 

(12,287

)

 

 

6,073

 

 
Income Tax Provision  

 

2,202

 

 

 

1,379

 

 
Net Income (Loss)  

$

(14,489

)

 

$

4,694

 

 
Net Income (Loss) per Common Share - Basic  

$

(1.93

)

 

$

0.63

 

 
Net Income (Loss) per Common Share - Diluted  

$

(1.93

)

 

$

0.63

 

 
           
Weighted Average Number of Common Shares - Basic  

 

7,509

 

 

 

7,415

 

 
Weighted Average Number of Common Shares - Diluted  

 

7,509

 

 

 

7,496

 

 
                   
ASTRONOVA, INC.  
Consolidated Balance Sheets  
In Thousands  
(Unaudited)  
           
    January 31,
2025
  January 31,
2024
 
ASSETS          
CURRENT ASSETS          
Cash and Cash Equivalents  

$

5,050

 

 

$

4,527

 

 
Accounts Receivable, net  

 

21,218

 

 

 

23,056

 

 
Inventories, net  

 

47,894

 

 

 

46,371

 

 
Prepaid Expenses and Other Current Assets  

 

3,855

 

 

 

2,720

 

 
Total Current Assets  

 

78,017

 

 

 

76,674

 

 
PROPERTY, PLANT AND EQUIPMENT  

 

62,361

 

 

 

57,046

 

 
Less Accumulated Depreciation  

 

(44,722

)

 

 

(42,861

)

 
Property, Plant and Equipment, net  

 

17,639

 

 

 

14,185

 

 
OTHER ASSETS          
Intangible Assets, net  

 

23,519

 

 

 

18,836

 

 
Goodwill  

 

14,515

 

 

 

14,633

 

 
Deferred Tax Assets  

 

8,431

 

 

 

6,882

 

 
Right of Use Asset  

 

1,781

 

 

 

603

 

 
Other Assets  

 

1,694

 

 

 

1,438

 

 
TOTAL ASSETS  

$

145,595

 

 

$

133,251

 

 
LIABILITIES AND SHAREHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts Payable  

$

7,928

 

 

$

8,068

 

 
Accrued Compensation  

 

3,745

 

 

 

2,923

 

 
Other Liabilities and Accrued Expenses  

 

4,461

 

 

 

2,706

 

 
Revolving Line of Credit  

 

20,929

 

 

 

8,900

 

 
Current Portion of Long-Term Debt  

 

6,110

 

 

 

2,842

 

 
Short-Term Debt  

 

581

 

 

 

-

 

 
Current Portion of Royalty Obligation  

 

1,358

 

 

 

1,700

 

 
Current Liability – Excess Royalty Payment Due  

 

691

 

 

 

935

 

 
Income Taxes Payable  

 

(0

)

 

 

349

 

 
Deferred Revenue  

 

543

 

 

 

1,338

 

 
Total Current Liabilities  

 

46,346

 

 

 

29,761

 

 
NON-CURRENT LIABILITIES          
Long-Term Debt, net of current portion  

 

19,044

 

 

 

10,050

 

 
Royalty Obligation, net of current portion  

 

1,106

 

 

 

2,093

 

 
Lease Liability, net of current portion  

 

1,535

 

 

 

415

 

 
Grant Deferred Revenue  

 

1,090

 

 

 

-

 

 
Income Tax Payables  

 

684

 

 

 

551

 

 
Deferred Tax Liabilities  

 

40

 

 

 

99

 

 
TOTAL LIABILITIES  

 

69,845

 

 

 

42,969

 

 
SHAREHOLDERS’ EQUITY          
Common Stock  

 

547

 

 

 

541

 

 
Additional Paid-in Capital  

 

64,215

 

 

 

62,684

 

 
Retained Earnings  

 

49,380

 

 

 

63,869

 

 
Treasury Stock  

 

(35,043

)

 

 

(34,593

)

 
Accumulated Other Comprehensive Loss, net of tax  

 

(3,349

)

 

 

(2,219

)

 
TOTAL SHAREHOLDERS’ EQUITY  

 

75,750

 

 

 

90,282

 

 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

145,595

 

 

$

133,251

 

 
                 

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flows

(In Thousands)

(Unaudited)

   

Twelve Months Ended

   

January 31,
2025

 

January 31,
2024

Cash Flows from Operating Activities:        
Net Income (Loss)  

$

(14,489

)

 

$

4,694

 

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:        
Depreciation and Amortization  

 

4,780

 

 

 

4,266

 

Grant Income Charged to Depreciation  

 

159

 

 

 

 

Goodwill Impairment  

 

13,403

 

 

 

 

Amortization of Debt Issuance Costs  

 

30

 

 

 

23

 

Restructuring Cost  

 

 

 

 

2,040

 

Share-Based Compensation  

 

1,378

 

 

 

1,347

 

Deferred Income Tax provision (Benefit)  

 

874

 

 

 

(78

)

Changes in Assets and Liabilities, net of impact of acquisition:        
Accounts Receivable  

 

2,859

 

 

 

(1,486

)

Inventories  

 

1,616

 

 

 

2,910

 

Accounts Payable and Accrued Expenses  

 

(2,379

)

 

 

(46

)

Deferred Revenue  

 

(1,520

)

 

 

 

Income Taxes  

 

(904

)

 

 

(343

)

Other  

 

(959

)

 

 

(973

)

Net Cash Provided by Operating Activities  

 

4,848

 

 

 

12,354

 

         
Cash Flows from Investing Activities:        
Purchases of Property, Plant and Equipment  

 

(1,165

)

 

 

(875

)

Cash Paid for MTEX Acquisition, net of cash acquired  

 

(19,109

)

 

 

 

Net Cash Provided (Used) for Investing Activities  

 

(20,274

)

 

 

(875

)

         
Cash Flows from Financing Activities:        
Net Cash Proceeds from Employee Stock Option Plans  

 

13

 

 

 

105

 

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan  

 

146

 

 

 

107

 

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock  

 

(450

)

 

 

(358

)

Net Borrowings under Revolving Credit Facility  

 

11,508

 

 

 

(7,000

)

Proceeds from Long-Term Debt Borrowings  

 

15,078

 

 

 

 

Payment of Minimum Guarantee Royalty Obligation  

 

(1,902

)

 

 

(1,725

)

Principal Payments of Long-Term Debt  

 

(8,980

)

 

 

(2,100

)

Payments of Debt Issuance Costs  

 

(35

)

 

 

 

Net Cash Provided (Used) for Financing Activities  

 

15,378

 

 

 

(10,971

)

         
Effect of Exchange Rate Changes on Cash and Cash Equivalents  

 

571

 

 

 

73

 

Net Increase in Cash and Cash Equivalents  

 

523

 

 

 

581

 

Cash and Cash Equivalents, Beginning of Period  

 

4,527

 

 

 

3,946

 

Cash and Cash Equivalents, End of Period  

$

5,050

 

 

$

4,527

 

         
Supplemental Disclosures of Cash Flow Information:        
Cash Paid During the Period for:        
Cash Paid During the Period for Interest  

$

2,701

 

 

$

2,343

 

Cash Paid During the Period for Income Taxes, net of refunds  

$

2,210

 

 

$

1,694

 

Non-Cash Transactions:        
Financed Equipment Purchase  

$

 

 

$

822

 

Capital Lease Obtained in Exchange for Capital Lease Liabilities  

$

1,581

 

 

$

 

             
ASTRONOVA, INC.
Revenue and Segment Operating Profit
In Thousands
(Unaudited)
                   
    Revenue   Segment Operating Profit  
    Three Months Ended   Three Months Ended  
    January 31,
2025
  January 31,
2024
  January 31,
2025
  January 31,
2024
 
Product Identification  

$

25,679

 

$

26,626

 

$

(11,174

)

 

$

3,239

 

 
Test & Measurement  

 

11,683

 

 

12,968

 

 

2,337

 

 

 

3,652

 

 
Total  

$

37,361

 

$

39,594

 

 

(8,837

)

 

 

6,891

 

 
General & Administrative Expenses          

 

3,473

 

 

 

2,976

 

 
Operating Income (Loss)          

 

(12,311

)

 

 

3,915

 

 
Interest Expense          

 

847

 

 

 

779

 

 
Other (Income)/Expense, net          

 

100

 

 

 

(216

)

 
Income (Loss) Before Income Taxes          

 

(13,258

)

 

 

3,352

 

 
Income Tax Provision          

 

2,342

 

 

 

641

 

 
Net Income (Loss)          

$

(15,600

)

 

$

2,711

 

 
                   
                   
    Revenue   Segment Operating Profit  
    Twelve Months Ended   Twelve Months Ended  
    January 31,
2025
  January 31,
2024
  January 31,
2025
  January 31,
2024
 
Product Identification  

$

102,345

 

$

104,041

 

$

(3,967

)

 

$

10,087

 

 
Test & Measurement  

 

48,938

 

 

44,045

 

 

11,143

 

 

 

10,200

 

 
Total  

$

151,283

 

$

148,086

 

 

7,176

 

 

 

20,287

 

 
General & Administrative Expenses          

 

15,816

 

 

 

11,491

 

 
Operating Income (Loss)          

 

(8,640

)

 

 

8,796

 

 
Interest Expense          

 

3,210

 

 

 

2,697

 

 
Other (Income)/Expense, net          

 

437

 

 

 

26

 

 
Income (Loss) Before Income Taxes          

 

(12,287

)

 

 

6,073

 

 
Income Tax Provision          

 

2,202

 

 

 

1,379

 

 
Net Income (Loss)          

$

(14,489

)

 

$

4,694

 

 
                   

Note: Segment Operating Profit excludes General & Administrative Expenses

             
               

ASTRONOVA, INC.

 
Reconciliation of GAAP to Non-GAAP Items  
In Thousands Except for Per Share Data  
(Unaudited)  
           
    Three Months Ended  
    January 31,
2025
  January 31,
2024
 
           
Gross Profit  

$

12,737

 

 

$

14,746

 

 
Inventory Step-Up  

 

62

 

 

 

-

 

 
Restructuring Charges, net  

 

-

 

 

 

(32

)

 
Product Retrofit Costs, net  

 

-

 

 

 

(210

)

 
Non-GAAP Gross Profit  

$

12,799

 

 

$

14,504

 

 
           
Operating Expenses  

$

25,048

 

 

$

10,831

 

 
MTEX-related Acquisition Expenses  

 

(254

)

 

 

0

 

 
Restructuring Charges, net  

 

-

 

 

 

43

 

 
Goodwill Impairment  

 

(13,403

)

 

 

-

 

 
Non-GAAP Operating Expenses  

$

11,392

 

 

$

10,874

 

 
           
Operating Income (Loss)  

$

(12,311

)

 

$

3,915

 

 
MTEX-related Acquisition Expenses  

 

254

 

 

 

(0

)

 
Inventory Step-Up  

 

62

 

 

 

-

 

 
Restructuring Charges, net  

 

-

 

 

 

(75

)

 
Product Retrofit Costs, net  

 

-

 

 

 

(210

)

 
Goodwill Impairment  

 

13,403

 

 

 

-

 

 
Non-GAAP Operating Income  

$

1,408

 

 

$

3,630

 

 
           
Net Income (Loss)  

$

(15,600

)

 

$

2,711

 

 
MTEX-related Acquisition Expenses, net  

 

197

 

 

 

(0

)

 
CFO Transition Costs, net  

 

(4

)

     
Inventory Step-Up, net  

 

50

 

 

 

-

 

 
Restructuring Charges, net  

 

-

 

 

 

(58

)

 
Product Retrofit Costs, net  

 

-

 

 

 

(162

)

 
Goodwill Impairment  

 

13,403

 

 

 

-

 

 
Tax Provision Valuation Allowance  

 

2,373

 

     
Non-GAAP Net Income  

$

419

 

 

$

2,491

 

 
           
Diluted Earnings Per Share  

$

(2.07

)

 

$

0.36

 

 
MTEX-related Acquisition Expenses  

 

0.03

 

 

 

(0.00

)

 
CFO Transition Costs, net  

 

(0.00

)

 

 

-

 

 
Inventory Step-Up  

 

0.01

 

 

 

-

 

 
Restructuring Charges, net  

 

-

 

 

 

(0.01

)

 
Product Retrofit Costs, net  

 

-

 

 

 

(0.02

)

 
Goodwill Impairment  

 

1.78

 

 

 

-

 

 
Tax Provision Valuation Allowance  

 

0.31

 

 

 

-

 

 
Non-GAAP Diluted Earnings Per Share  

$

0.06

 

 

$

0.33

 

 
           
    Twelve Months Ended  
    January 31,
2025
  January 31,
2024
 
           
Gross Profit  

$

52,749

 

 

$

51,621

 

 
Inventory Step-Up  

 

216

 

 

 

-

 

 
Restructuring Charges  

 

-

 

 

 

2,064

 

 
Product Retrofit Costs  

 

-

 

 

 

642

 

 
Non-GAAP Gross Profit  

$

52,966

 

 

$

54,327

 

 
           
Operating Expenses  

$

61,389

 

 

$

42,825

 

 
MTEX-related Acquisition Expenses  

 

(1,204

)

 

 

0

 

 
CFO Transition Costs  

 

(432

)

     
Restructuring Charges  

 

-

 

 

 

(512

)

 
Goodwill Impairment  

 

(13,403

)

 

 

-

 

 
Non-GAAP Operating Expenses  

$

46,350

 

 

$

42,313

 

 
           
Operating Income (Loss)  

$

(8,640

)

 

$

8,796

 

 
MTEX-related Acquisition Expenses  

 

1,204

 

 

 

(0

)

 
CFO Transition Costs  

 

432

 

     
Inventory Step-Up  

 

216

 

 

 

-

 

 
Restructuring Charges  

 

-

 

 

 

2,576

 

 
Product Retrofit Costs  

 

-

 

 

 

642

 

 
Goodwill Impairment  

 

13,403

 

 

 

-

 

 
Non-GAAP Operating Income  

$

6,615

 

 

$

12,014

 

 
           
Net Income (Loss)  

$

(14,489

)

 

$

4,694

 

 
MTEX-related Acquisition Expenses, net  

 

910

 

 

 

(0

)

 
CFO Transition Costs, net  

 

328

 

 

 

-

 

 
Inventory Step-Up, net  

 

161

 

 

 

-

 

 
Restructuring Charges, net  

 

-

 

 

 

1,990

 

 
Product Retrofit Costs, net  

 

-

 

 

 

496

 

 
Goodwill Impairment  

 

13,403

 

 

 

-

 

 
Tax Provision  

 

2,373

 

     
Non-GAAP Net Income  

$

2,686

 

 

$

7,180

 

 
           
Diluted Earnings Per Share  

$

(1.93

)

 

$

0.63

 

 
MTEX-related Acquisition Expenses  

 

0.12

 

 

 

(0.00

)

 
CFO Transition Costs  

 

0.04

 

 

 

-

 

 
Inventory Step-Up  

 

0.02

 

 

 

-

 

 
Restructuring Charges  

 

-

 

 

 

0.27

 

 
Product Retrofit Costs  

 

-

 

 

 

0.07

 

 
Goodwill Impairment  

 

1.76

 

 

 

-

 

 
Tax Provision Valuation Allowance  

 

0.31

 

 

 

-

 

 
Non-GAAP Diluted Earnings Per Share  

$

0.33

 

 

$

0.97

 

 
                   
ASTRONOVA, INC.  
Reconciliation of Net Income to Adjusted EBITDA  
Amounts In Thousands  
(Unaudited)  
       
  Three Months Ended  
  January 31, 2025 January 31, 2024  
       
Net Income (Loss)

$

(15,600

)

$

2,711

 

 
Interest Expense

 

847

 

 

779

 

 
Income Tax Expense

 

2,342

 

 

641

 

 
Depreciation & Amortization

 

1,266

 

 

1,108

 

 
EBITDA

$

(11,146

)

$

5,239

 

 
Share-Based Compensation

 

219

 

 

282

 

 
MTEX-related Acquisition Expenses

 

259

 

 

-

 

 
CFO Transition Costs

 

(5

)

 

-

 

 
Inventory Step-Up

 

62

 

 

-

 

 
Goodwill Impairment

 

13,403

 

 

-

 

 
Restructuring Charges

 

-

 

 

(75

)

 
Product Retrofit Costs

 

-

 

 

(210

)

 
Adjusted EBITDA

$

2,793

 

$

5,236

 

 
       
  Twelve Months Ended  
  January 31, 2025 January 31, 2024  
       
Net Income (Loss)

$

(14,489

)

$

4,694

 

 
Interest Expense

 

3,210

 

 

2,697

 

 
Income Tax Expense (Benefit)

 

2,202

 

 

1,379

 

 
Depreciation & Amortization

 

4,780

 

 

4,266

 

 
EBITDA

$

(4,297

)

$

13,036

 

 
Share-Based Compensation

 

1,378

 

 

1,347

 

 
MTEX-related Acquisition Expenses

 

1,204

 

 

-

 

 
CFO Transition Costs

 

432

 

 

-

 

 
Inventory Step-Up

 

216

 

 

-

 

 
Goodwill Impairment

 

13,403

 

 

-

 

 
Restructuring Charges

 

-

 

 

2,576

 

 
Product Retrofit Costs

 

-

 

 

642

 

 
Adjusted EBITDA

$

12,336

 

$

17,601

 

 
               
ASTRONOVA, INC.  
Reconciliation of Segment Operating Income to Non-GAAP Segment Operating Income  
Amounts In Thousands  
(Unaudited)  
                 
  Three Months Ended  
  January 31, 2025   January 31, 2024  
  Product
Identification
Test &
Measurement
Total   Product
Identification
Test &
Measurement
Total  
                 
Segment Operating Profit (Loss)

$

(11,174

)

$

2,337

$

(8,837

)

 

$

3,239

 

$

3,652

$

6,891

 

 
                 
Inventory Step-Up

 

62

 

 

-

 

62

 

 

 

-

 

 

-

 

-

 

 
                 
Restructuring Charges

 

-

 

 

-

 

-

 

 

 

(75

)

 

-

 

(75

)

 
                 
Product Retrofit Costs

 

-

 

 

-

 

-

 

 

 

(210

)

 

-

 

(210

)

 
                 
Goodwill Impairment

 

13,403

 

 

-

 

13,403

 

 

 

-

 

 

-

 

-

 

 
                 
Non-GAAP - Segment Operating Profit

$

2,291

 

$

2,337

$

4,628

 

 

$

2,954

 

$

3,652

$

6,606

 

 
                 
  Twelve Months Ended  
  January 31, 2025   January 31, 2024  
  Product
Identification
Test &
Measurement
Total   Product
Identification
Test &
Measurement
Total  
                 
Segment Operating Profit (Loss)

$

(3,967

)

$

11,143

$

7,176

 

 

$

10,087

 

$

10,200

$

20,287

 

 
                 
Inventory Step-Up

 

216

 

 

-

 

216

 

 

 

-

 

 

-

 

-

 

 
                 
Restructuring Charges

 

-

 

 

-

 

-

 

 

 

2,494

 

 

-

 

2,494

 

 
                 
Product Retrofit Costs

 

-

 

 

-

 

-

 

 

 

642

 

 

-

 

642

 

 
                 
Goodwill Impairment

 

13,403

 

 

-

 

13,403

 

 

 

-

 

 

-

 

-

 

 
                 
Non-GAAP - Segment Operating Profit

$

9,652

 

$

11,143

$

20,795

 

 

$

13,223

 

$

10,200

$

23,423

 

 
                                     
Note: Segment Operating Profit excludes General & Administrative Expenses                    
                     

ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP Items for PI Segment

Amounts In Thousands

(Unaudited)
                                       
  Three Months Ended January 31, 2025   Three Months Ended January 31, 2024
                  Non-GAAP                
  Total PI Segment as Reported   MTEX as Reported   Inventory Step-Up   Goodwill Impairment   Adj MTEX   PI Excluding MTEX   Total PI Segment as Reported   Restructuring Charges   Product Retrofit Costs   PI (Non-GAAP)
Net Revenue

$

25,679

 

 

$

1,657

 

         

$

1,657

 

 

$

24,022

 

$

26,626

         

$

26,626

Cost of Revenue

 

17,108

 

 

 

1,313

 

 

 

(62

)

     

 

1,251

 

 

 

15,795

 

 

17,215

 

 

75

 

 

 

210

 

 

 

17,500

Gross Profit

 

8,571

 

 

 

344

 

 

 

62

 

 

 

-

 

 

 

406

 

 

 

8,227

 

 

9,411

 

 

(75

)

 

 

(210

)

 

 

9,126

Selling & Marketing

 

5,439

 

 

 

730

 

         

 

730

 

 

 

4,709

 

 

5,121

         

 

5,121

Research & Development

 

904

 

 

 

198

 

         

 

198

 

 

 

706

 

 

1,051

         

 

1,051

Goodwill Impairment

 

13,403

 

 

 

13,403

 

     

 

(13,403

)

 

 

-

 

 

 

-

 

 

-

         

 

-

Operating Expenses

 

19,746

 

 

 

14,331

 

 

 

-

 

 

 

(13,403

)

 

 

928

 

 

 

5,415

 

 

6,172

 

 

-

 

 

 

-

 

 

 

6,172

Segment Operating Profit (Loss)

$

(11,175

)

 

$

(13,987

)

 

$

62

 

 

$

13,403

 

 

$

(522

)

 

$

2,812

 

$

3,239

 

$

(75

)

 

$

(210

)

 

$

2,954

                                       
                                       
  Twelve Months Ended January 31, 2025   Twelve Months Ended January 31, 2024
                  Non-GAAP                
  Total PI Segment as Reported   MTEX as Reported   Inventory Step-Up   Goodwill Impairment   Adj MTEX   PI Excluding MTEX   Total PI Segment as Reported   Restructuring Charges   Product Retrofit Costs   PI (Non-GAAP)
Net Revenue

$

102,345

 

 

$

4,163

 

         

$

4,163

 

 

$

98,182

 

$

104,041

         

$

104,041

Cost of Revenue

 

68,420

 

 

 

3,652

 

 

 

(216

)

     

 

3,436

 

 

 

64,768

 

 

69,064

 

 

(2,494

)

 

 

(642

)

 

 

65,928

Gross Profit

 

33,925

 

 

 

511

 

 

 

216

 

 

 

-

 

 

 

727

 

 

 

33,414

 

 

34,977

 

 

2,494

 

 

 

642

 

 

 

38,113

Selling & Marketing

 

21,386

 

 

 

2,485

 

         

 

2,485

 

 

 

18,901

 

 

20,601

 

 

-

 

     

 

20,601

Research & Development

 

3,104

 

 

 

309

 

         

 

309

 

 

 

2,795

 

 

4,289

 

 

-

 

     

 

4,289

Goodwill Impairment

 

13,403

 

 

 

13,403

 

     

 

(13,403

)

 

 

-

 

 

 

-

 

 

0

 

 

-

 

     

 

0

Operating Expenses

 

37,893

 

 

 

16,197

 

 

 

-

 

 

 

(13,403

)

 

 

2,794

 

 

 

21,696

 

 

24,890

 

 

-

 

 

 

-

 

 

 

24,890

Segment Operating Profit (Loss)

$

(3,968

)

 

$

(15,686

)

 

$

216

 

 

$

13,403

 

 

$

(2,067

)

 

$

11,718

 

$

10,087

 

$

2,494

 

 

$

642

 

 

$

13,223

                                       
Note: Segment Operating Profit (Loss) excludes General & Administrative Expenses. MTEX General & Administrative Expenses of $411k for the three months ended January 31, 2025 and $1,194k for the twelve months ended January 31, 2025 results in Adjusted MTEX Non-GAAP Operating Loss of $933k for the three months ended January 31, 2025 and $3,261k for the twelve months ended January 31, 2025.

 

Tom DeByle
Vice President, Chief Financial Officer & Treasurer
AstroNova, Inc.
(401) 828-4000

Scott Solomon
Senior Vice President
Sharon Merrill Advisors
(857) 383-2409
ALOT@investorrelations.com

Source: AstroNova
Multimedia Files:
  • Multimedia JPG file for AstroNova Reports Fiscal 2025 Fourth-Quarter and Full-Year Financial Results; Advancing Restructuring, Operational Realignment and Product Simplification Plans to Drive Improved Earnings Power
    Download:
    Download original 265 KB (3000 x 600) Download image: Multimedia file for AstroNova Reports Fiscal 2025 Fourth-Quarter and Full-Year Financial Results; Advancing Restructuring, Operational Realignment and Product Simplification Plans to Drive Improved Earnings Power as a original in JPG format. Opens in a new window
    Download thumbnail 5 KB (200 x 40) Download image: Multimedia file for AstroNova Reports Fiscal 2025 Fourth-Quarter and Full-Year Financial Results; Advancing Restructuring, Operational Realignment and Product Simplification Plans to Drive Improved Earnings Power as a thumbnail in JPG format. Opens in a new window
    Download lowres 16 KB (480 x 96) Download image: Multimedia file for AstroNova Reports Fiscal 2025 Fourth-Quarter and Full-Year Financial Results; Advancing Restructuring, Operational Realignment and Product Simplification Plans to Drive Improved Earnings Power as a lowres in JPG format. Opens in a new window
    Download square 8 KB (250 x 250) Download image: Multimedia file for AstroNova Reports Fiscal 2025 Fourth-Quarter and Full-Year Financial Results; Advancing Restructuring, Operational Realignment and Product Simplification Plans to Drive Improved Earnings Power as a square in JPG format. Opens in a new window

IR Contact

AstroNova, Inc.
Investor Relations Department
600 East Greenwich Avenue
West Warwick, RI 02893
Deborah Pawlowski
Alliance Advisors IR
Phone: (716) 843-3908
Email: ALOT@allianceadvisors.com

Email Alerts

Email Address *

 
Enter the code shown above.

Interactive Analyst Center Disclaimer

The financial data and other material provided to users in the pages of the website is for information purposes only. Users should not rely on information on this website for any purpose other than for obtaining general knowledge of AstroNova. Material may be changed or updated without notice.

AstroNova, Inc.

Ok